StockData
Tevogen Inc. logo

Tevogen Inc. (TVGNW) stock

TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.09+0.01 (+18.24%)

Close on Oct 30, 2026Market cap $38.42MP/E –Yield –

Tevogen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Tevogen's shares outstanding was 4M at Jun 30, 2026. For fiscal 2025 it was 3M, up 13.2% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20253M+13.2%
FY2024Dec 31, 20243M+492.6%
FY2023Dec 31, 20230M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20264M+16.3%
Q1 FY2026Mar 31, 20263M+8.0%
Q4 FY2025Dec 31, 20252M-3.7%
Q3 FY2025Sep 30, 20254M+15.2%
Q2 FY2025Jun 30, 20253M+6.8%
Q1 FY2025Mar 31, 20253M+13.4%
Q4 FY2024Dec 31, 20242M+331.0%
Q3 FY2024Sep 30, 20243M+41.8%
Q2 FY2024Jun 30, 20243M+28.5%
Q1 FY2024Mar 31, 20243M+18.7%
Q4 FY2023Dec 31, 20230M-31.1%
Q3 FY2023Sep 30, 20232M+1062.8%
Q2 FY2023Jun 30, 20232M–
Q1 FY2023Mar 31, 20232M–
Q1 FY2022Mar 31, 20221M–
Q3 FY2021Sep 30, 20210M–

More Tevogen figures